Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasuhide Tei is active.

Publication


Featured researches published by Yasuhide Tei.


Scandinavian Journal of Urology and Nephrology | 2003

Granulocyte colony-stimulating factor may promote proliferation of human bladder cancer cells mediated by basic fibroblast growth factor.

Chietaka Ohmi; Hideyasu Matsuyama; Yasuhide Tei; Satoru Yoshihiro; Tomoyuki Shimabukuro; Yasukazu Ohmoto; Katsusuke Naito

Objectives: To investigate whether granulocyte colony-stimulating factor (G-CSF) promotes the proliferation of two bladder cancer cell lines, and to assess the mechanism of tumor proliferation in terms of cytokine expression. Material and Methods: The proliferation of two bladder cancer cell lines derived from transitional cell carcinoma (KK-47 and T-24) was assessed by using the double-layer soft agarose colony assay in combination with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Seven cytokines were measured in the culture supernatant. Expression of granulocyte colony-stimulating factor (G-CSF) receptor and fibroblast growth factor (FGF) receptor mRNA was studied by means of reverse transcriptase polymerase chain reaction (RT-PCR). Results: Recombinant human G-CSF (rhG-CSF) caused greater induction of the proliferation of KK-47 cells in the presence than in the absence of peripheral blood mononuclear cells (PBMCs) and its effect was dose-dependent. In contrast, rhG-CSF did not stimulate the proliferation of T-24 cells. Among several cytokines measured, only basic FGF was elevated in cultures of KK-47 cells with or without PBMCs. The basic FGF level was significantly increased by rhG-CSF stimulation in a dose-dependent manner. Specific PCR products for the G-CSF and FGF receptors were observed in KK-47 cells as well as PBMC, while no G-CSF receptor was detected in T-24 cells. Conclusion: rhG-CSF may promote the proliferation of KK-47 cells, probably via an increase in basic FGF production.


Cancer Immunology, Immunotherapy | 2003

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder

Etsuya Watanabe; Hideyasu Matsuyama; Kenji Matsuda; Chietaka Ohmi; Yasuhide Tei; Satoru Yoshihiro; Yasukazu Ohmoto; Katsusuke Naito


International Journal of Clinical Oncology | 2016

Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer

Takahiko Hara; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Takahito Nasu; Keiji Joko; Yoshikazu Baba; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; M Konishi; Sigeru Sakano; Katsuhiko Imoto; Yasuhide Tei; Shiro Yamaguchi; Seiji Yano


Anticancer Research | 2002

In vitro antitumor activity of bropirimine against urinary bladder tumor cells.

Yasuhide Tei; Hideyasu Matsuyama; Takashi Wada; Hiroaki Kurisu; Makoto Tahara; Katsusuke Naito


Hinyokika kiyo. Acta urologica Japonica | 2006

Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.

Tomoyuki Shimabukuro; Kanehiro Nakamura; Kouichi Uchiyama; Yasuhide Tei; Akihiko Aoki; Katsusuke Naito


Nihon Toseki Igakkai Zasshi | 2002

A case of intravesical BCG instillation for bladder cancer in a patient receiving hemodialysis

Satoru Yoshihiro; Etsuya Watanabe; Chietaka Ohmi; Yasuhide Tei; Akihiko Aoki; Mitsutaka Yamamoto; Hideyasu Matsuyama; Yoshitaka Kaneda; Katsusuke Naito


International Journal of Clinical Oncology | 2018

Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?

Kazuhiro Nagao; Hideyasu Matsuyama; Hiroaki Matsumoto; Takahito Nasu; Mitsutaka Yamamoto; Yoriaki Kamiryo; Yoshikazu Baba; Akinobu Suga; Yasuhide Tei; Satoru Yoshihiro; Akihiko Aoki; Tomoyuki Shimabukuro; Keiji Joko; Shigeru Sakano; Kimio Takai; Shiro Yamaguchi; Jumpei Akao; Seiji Kitahara


泌尿器科紀要 | 2006

局所進行性膀胱癌に対するAngiotensin-2併用動脈内注入化学療法:単独施設における症例集積研究

智之 島袋; 金弘 中村; 浩一 内山; Yasuhide Tei; Akihiko Aoki; Katsusuke Naito


Nishi Nihon hinyokika | 2005

Renal biopsy : Clinicopathological study of 126 patients

Tomoyuki Shimabukuro; Kanehiro Nakamura; Kouichi Uchiyama; Yasuhide Tei; Katsusuke Naito


Nishi Nihon hinyokika | 2004

Our experience with extracorporeal shock-wave lithotripsy in upper urinary stone management and analytical aspects of the stones

Tomoyuki Shimabukuro; Kanehiro Nakamura; Kouichi Uchiyama; Yasuhide Tei; Katsusuke Naito

Collaboration


Dive into the Yasuhide Tei's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge